Matthew P. Ottmer
2017
In 2017, Matthew P. Ottmer earned a total compensation of $1.8M as Former Chief Operating Officer at Momenta Pharmaceuticals, a 24% increase compared to previous year.
Compensation breakdown
Option Awards | $460,920 |
---|---|
Salary | $153,316 |
Stock Awards | $452,400 |
Other | $725,839 |
Total | $1,792,475 |
Ottmer received $725.8K in other compensation, accounting for 40% of the total pay in 2017.
Ottmer also received $460.9K in option awards, $153.3K in salary and $452.4K in stock awards.
Rankings
In 2017, Matthew P. Ottmer's compensation ranked 6,049th out of 14,666 executives tracked by ExecPay. In other words, Ottmer earned more than 58.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,049 out of 14,666 | 59th |
Division Manufacturing | 2,221 out of 5,772 | 62nd |
Major group Chemicals And Allied Products | 702 out of 2,075 | 66th |
Industry group Drugs | 541 out of 1,731 | 69th |
Industry Biological Products, Except Diagnostic Substances | 99 out of 313 | 68th |
Source: SEC filing on April 27, 2018.
Ottmer's colleagues
We found five more compensation records of executives who worked with Matthew P. Ottmer at Momenta Pharmaceuticals in 2017.
2017
Craig Wheeler
Momenta Pharmaceuticals
Chief Executive Officer
2017
Santiago Arroyo
Momenta Pharmaceuticals
Chief Medical Officer
2017
Ganesh Kaundinya
Momenta Pharmaceuticals
Chief Operating Officer
2017
Bruce Leicher
Momenta Pharmaceuticals
General Counsel
2017
Scott Storer
Momenta Pharmaceuticals